Prospective, Randomized, Multi-centric, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of KSM-66 Ashwagandha (Withania somnifera) in Adults Experiencing High Stress and/or Anxiety: Clinical Study Protocol
D Y Patil Journal of Health Sciences · 2026-04 · 14 (2) · 119-122
DOI: 10.4103/dypj.dypj_33_25 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift D Y Patil Journal of Health Sciences, online erschienen am 14.08.2026. Verfasst von Deepak Langade und 2 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Modern life often leads to stress, manifesting physical symptoms like fatigue and headaches, as well as emotional effects such as anxiety and mood changes. Ashwagandha ( Withania somnifera ), a key medicinal plant in Indian Ayurveda, is renowned for its anti-stress and vitality-enhancing properties. This study aims to assess the efficacy and safety of Ashwagandha root extract in adults experiencing high stress and anxiety. Materials and Methods: This study is a prospective, randomized, multi-national, multi-center, double-blind, placebo-controlled trial designed to assess the safety and tolerability of Ashwagandha ( Withania somnifera ) root extract (ARE) in adults across different populations. The primary focus of the overall trial is on stress and anxiety reduction; this segment specifically investigates the safety and tolerability of ARE in an adult population. A total of 1000 subjects with anxiety and stress disorders were enrolled in the study.
Conclusion
This study will provide compelling evidence that KSM-66 Ashwagandha root extract is a safe and well-tolerated intervention for reducing stress and managing anxiety in healthy adults.
Zitieren
APA
Langade, D., Salve, J., & Sampara, P. (2026). Prospective, Randomized, Multi-centric, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of KSM-66 Ashwagandha (Withania somnifera) in Adults Experiencing High Stress and/or Anxiety: Clinical Study Protocol. D Y Patil Journal of Health Sciences, 14(2), 119-122. https://doi.org/10.4103/dypj.dypj_33_25
Vancouver
Langade D, Salve J, Sampara P. Prospective, Randomized, Multi-centric, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of KSM-66 Ashwagandha (Withania somnifera) in Adults Experiencing High Stress and/or Anxiety: Clinical Study Protocol. D Y Patil Journal of Health Sciences. 2026;14(2):119-122. doi:10.4103/dypj.dypj_33_25
BibTeX
@article{Langade2026,
author = {Langade, Deepak and Salve, Jaising and Sampara, Prasanthi},
title = {Prospective, Randomized, Multi-centric, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of KSM-66 Ashwagandha (Withania somnifera) in Adults Experiencing High Stress and/or Anxiety: Clinical Study Protocol},
journal = {D Y Patil Journal of Health Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {119--122},
doi = {10.4103/dypj.dypj_33_25}
}
EUVIMED